MDS-1047: RENEW Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate Elritercept in Participants With Transfusion-Dependent Anemia and Lower-Risk Myelodysplastic Neoplasms
Rami S. Komrokji(Moffitt Cancer Center), Jen L. Salstrom(Unknown), Pierre Fenaux(Saint Louis University Hospital), Christopher Rovaldi, Amy E. DeZern(Johns Hopkins University), Rena Buckstein(Sunnybrook Health Science Centre), Matteo Della Porta(University of Milan), Miranda Ross, Mikkael A. Sekeres(University of Miami), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Amer M. Zeidan(Yale Cancer Center), Chris Materna, Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), María Diez‐Campelo(Universidad de Salamanca), Montagu Hankin, A. Giagounidis(Marien Hospital Düsseldorf), Lynette Chee(The Royal Melbourne Hospital), Dena Grayson
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k